BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32779191)

  • 1. The impact of the COVID-19 pandemic on the Management of Locally Advanced Primary/Recurrent Rectal Cancer.
    PelvEx Collaborative
    Br J Surg; 2020 Oct; 107(11):e547-e548. PubMed ID: 32779191
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative radiotherapy for locally advanced rectal cancer during and after the COVID-19 pandemic.
    Mirnezami R; Knowles J; Kar A; Glynne-Jones R
    Br J Surg; 2020 Jul; 107(8):e263. PubMed ID: 32463479
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of the COVID-19 pandemic on colorectal cancer service provision.
    CRC COVID Research Collaborative
    Br J Surg; 2020 Oct; 107(11):e521-e522. PubMed ID: 32856751
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment approach in locally advanced rectal cancer during coronavirus (COVID-19) pandemic: long course or short course?
    De Felice F; Petrucciani N
    Colorectal Dis; 2020 Jun; 22(6):642-643. PubMed ID: 32237263
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of COVID-19 on treatment modalities and short-term outcomes of rectal cancer following neoadjuvant chemoradiotherapy: a retrospective study.
    Dong DZ; Dong QS; Zhang FN; Li CL; Wang L; Li YH; Wang WH; Wu AW
    Br J Surg; 2021 Apr; 108(4):e164-e165. PubMed ID: 33793768
    [No Abstract]   [Full Text] [Related]  

  • 6. Trends in Top Cancer Diagnosis and Challenges Related to COVID-19 Pandemic.
    Ehrlich H; Sen-Crowe B; McKenney M; Elkbuli A
    Am Surg; 2020 Nov; 86(11):1515-1517. PubMed ID: 32856936
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined modality treatment including IORT in locally advanced and recurrent rectal cancer: results from a prospective Norwegian study.
    Tveit KM; Wiig JN; Olsen DR; Storaas A; Poulsen JP; Giercksky KE
    Front Radiat Ther Oncol; 1997; 31():221-3. PubMed ID: 9263827
    [No Abstract]   [Full Text] [Related]  

  • 8. Myeloma care adaptations in the UK during SARS-CoV-2 pandemic: Challenges and measurable outcomes.
    Djebbari F; Panitsas F; Sharpley FA; Rampotas A; Larham J; Moore S; Gooding S; Kothari J; Ramasamy K
    Eur J Haematol; 2020 Nov; 105(5):662-666. PubMed ID: 32592210
    [No Abstract]   [Full Text] [Related]  

  • 9. [The diagnosis and therapy of recurrent tumor of the rectum].
    Cafiero F; Gipponi M; Pirisi E; Bertoglio S; Moresco L; Spiccio M; Percivale P; Badellino F
    Minerva Chir; 1991 Apr; 46(7):311-6. PubMed ID: 1866038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined modality treatment for locally recurrent rectal cancer.
    Sommer K; Brockmann WP; Wiegel T; Hübener KH
    Int J Radiat Oncol Biol Phys; 1992; 24(1):187-8. PubMed ID: 1512160
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of locally recurrent rectal cancer with special focus on regional pelvic hyperthermia.
    Hildebrandt B; Wust P; Gellermann J; Nicolaou A; Trappe RU; Felix R; Riess H; Rau B
    Onkologie; 2004 Oct; 27(5):506-11. PubMed ID: 15585984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective single-arm study of intraoperative radiotherapy for locally advanced or recurrent rectal cancer.
    Tan J; Heriot AG; Mackay J; Van Dyk S; Bressel MA; Fox CD; Hui AC; Lynch AC; Leong T; Ngan SY
    J Med Imaging Radiat Oncol; 2013 Oct; 57(5):617-25. PubMed ID: 24119279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Glimelius B; Oliveira J;
    Ann Oncol; 2008 May; 19 Suppl 2():ii31-2. PubMed ID: 18456759
    [No Abstract]   [Full Text] [Related]  

  • 14. Extent of mesorectal invasion is a prognostic indicator in T3 rectal carcinoma.
    Church JM
    ANZ J Surg; 2002 Jul; 72(7):460. PubMed ID: 12123497
    [No Abstract]   [Full Text] [Related]  

  • 15. Facial Abrikosoff tumour: The role of the dermatologist during COVID-19 pandemic.
    Orsini D; D'Arino A; Tedesco M; Cota C; Pigliacelli F; Assorgi C; Latini A; Cristaudo A; Morrone A
    Int Wound J; 2020 Dec; 17(6):2026-2027. PubMed ID: 32573933
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances in the management of rectal cancer.
    Maslekar S; Anwar S
    Br J Hosp Med (Lond); 2008 Dec; 69(12):681-5. PubMed ID: 19186605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a Surgical Oncology Hub during the COVID-19 Pandemic: Lessons Learned from the United Kingdom.
    Kayani B; Roberts L; Haddad FS
    Br J Surg; 2020 Oct; 107(11):e510-e511. PubMed ID: 32820827
    [No Abstract]   [Full Text] [Related]  

  • 18. Conducting clinical surgical examinations in Timor-Leste during the COVID-19 global pandemic.
    Salendo J; Soares A; de Sousa Saldanha Soares SB; Martins J; Korin S; Nagra S; Watters D; McCaig E; Guest G
    ANZ J Surg; 2020 Dec; 90(12):2399-2401. PubMed ID: 33336482
    [No Abstract]   [Full Text] [Related]  

  • 19. [Surgical treatment outcomes of multimodality therapy for locally recurrent rectal cancer].
    Koyama M; Murata A; Sakamoto Y; Morohashi H; Hasebe T; Saito T; Awatsu A; Abo E; Terui K; Hakamada K
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1459-61. PubMed ID: 25731218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidisciplinary management of early-stage rectal cancer.
    Phillips JG; Hong TS; Ryan DP
    J Natl Compr Canc Netw; 2012 Dec; 10(12):1577-85. PubMed ID: 23221792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.